As the Cincinnati Reds fired manager David Bell on Sunday night, they made the first move of a pivotal offseason. Hiring a new manager will be the first step in a busy winter that will shape how s ...
(RTTNews) - Gilead Sciences Inc. (GILD) announced that additional data from its pivotal Phase 3 PURPOSE 2 trial demonstrated a 96% reduction in HIV infections with Lenacapavir compared to the ...
Gilead Sciences GILD underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their ...
International AIDS Society, an association of HIV/AIDS professionals, applauded moves by Gilead Sciences, a biopharma company, to make the generic injectable lenacapavir for HIV prevention widely ...
Oct 3 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Thursday it would donate about 5,000 vials of its antiviral drug remdesivir to the Rwanda Medical Supply for emergency use in ...
American biopharmaceutical company Gilead Sciences, on Thursday, October 3, announced that it will donate about 5,000 vials of its antiviral drug Remdesivir for emergency use in response to the ...
Six drugmakers have inked voluntary licensing (VL) agreements with Gilead Sciences to manufacture and distribute generic lenacapavir, a long-acting injectable HIV drug from the American drugmaker.
Responding to today's announcement by Gilead on lenacapavir, UNAIDS Executive Director Winnie Byanyima said: "We welcome Gilead's announcement of licensing the break-through HIV medicine lenacapavir ...
Oct 2 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell cheaper copycat versions of its ...
WASHINGTON, United States (AFP) — US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower ...
The Ig Nobel awards, an annual ceremony for laugh-out-loud scientific papers, celebrate the joyfully improbable nature of much academic research. One of this year’s Ig Nobel winners, “Factors ...
Gilead announced Wednesday that it will allow certain drug manufacturers to make and sell a generic version of its twice-yearly HIV … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback